Variant report
Variant | esv3443893 |
---|---|
Chromosome Location | chr13:92558601-92560899 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561054859 | chr13:92558637-92558638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530012717 | chr13:92558652-92558653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374183115 | chr13:92558715-92558716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145841913 | chr13:92558752-92558753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs202246874 | chr13:92558766-92558767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539008653 | chr13:92558804-92558805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148585205 | chr13:92558821-92558822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115214268 | chr13:92558836-92558837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538084852 | chr13:92558858-92558859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182908360 | chr13:92558904-92558905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375316886 | chr13:92558957-92558958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528373287 | chr13:92559005-92559006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568703027 | chr13:92559053-92559054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534233074 | chr13:92559064-92559065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553999897 | chr13:92559088-92559089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572525445 | chr13:92559100-92559101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544567675 | chr13:92559148-92559149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs142997027 | chr13:92559160-92559161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187726130 | chr13:92559165-92559166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34091631 | chr13:92559340-92559341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138581723 | chr13:92559341-92559342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9560886 | chr13:92559383-92559384 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs191071927 | chr13:92559446-92559447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146603095 | chr13:92559448-92559449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540535637 | chr13:92559478-92559479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560455945 | chr13:92559589-92559590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532586505 | chr13:92559610-92559611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182124097 | chr13:92559636-92559637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141363771 | chr13:92559653-92559654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs36190602 | chr13:92559671-92559672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141939305 | chr13:92559672-92559673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs397772989 | chr13:92559681-92559682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372355846 | chr13:92559682-92559683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375493830 | chr13:92559683-92559684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569302102 | chr13:92559734-92559735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs201611577 | chr13:92559753-92559754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199620467 | chr13:92559755-92559756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369447673 | chr13:92559757-92559758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138444594 | chr13:92559765-92559766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs58557370 | chr13:92559779-92559780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531826020 | chr13:92559821-92559822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548355008 | chr13:92559851-92559852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568320540 | chr13:92559897-92559898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369061993 | chr13:92559903-92559904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145316929 | chr13:92559908-92559909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114149194 | chr13:92559948-92559949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146458327 | chr13:92559972-92559973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9589368 | chr13:92560048-92560049 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201479471 | chr13:92560050-92560051 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558520959 | chr13:92560074-92560075 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92558400-92559000 | Enhancers | HUVEC | blood vessel |
2 | chr13:92559000-92559600 | Weak transcription | HUVEC | blood vessel |
3 | chr13:92559600-92560000 | Enhancers | HUVEC | blood vessel |
4 | chr13:92560000-92560600 | Flanking Active TSS | HUVEC | blood vessel |
5 | chr13:92560600-92561400 | Active TSS | HUVEC | blood vessel |